Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
ACS Applied Materials & Interfaces|June 27, 2022
Multifunctional Selenium Nanoparticles with Different Surface Modifications Ameliorate Neuroinflammation through the Gut Microbiota-NLRP3 Inflammasome-Brain Axis in APP/PS1 MiceLicong Yang, Yanan Cui, Hanji Liang, et al.
Tobacco Induced Diseases|January 26, 2024
PU.1 alleviates the inhibitory effects of cigarette smoke on endothelial progenitor cell function and lung-homing through Wnt/β-catenin and CXCL12/CXCR4 pathwaysXue He, Yanan Cui, Tiao Li, et al.
Cancers|February 15, 2022
c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone DeacetylationPeiyan Zhao, Xiaodan Sun, Hui Li, et al.
Pediatric Neurology|January 30, 2019
Prognostic Value of Electroencephalography in Hypothermia-Treated Neonates With Hypoxic-Ischemic Encephalopathy: A Meta-AnalysisYe Han, Na Fu, Wenjie Chen, et al.
International Journal of Pharmaceutics|September 20, 2012
Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluationFei Han, Ran Yin, Xin Che, et al.
Medicine|December 10, 2024
Identification of gene signatures relevant to the efficacy of immune checkpoint inhibitors in non-small cell lung cancerMin Liu, Qiao Li, Xiaohong Meng, et al.
Biosensors & Bioelectronics|June 7, 2026
Split-type electrochemiluminescence immunosensor for h-FABP: Performance enhancement through site-oriented antibody immobilization on magnetic beads and intra-reticular charge transfer-based luminophoresJinglong Fang, Wenwen Liu, Yifan Zhong, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2024
Tumor-exosomal miR-205-5p as a diagnostic biomarker for colorectal cancerYajing Zhao, Yapeng Zhao, Lisheng Liu, et al.
Thoracic Cancer|September 12, 2021
Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancerChen Zhang, Honggang Cao, Yanan Cui, et al.
Thoracic Cancer|January 3, 2023
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysisJiali Dai, Xinyin Liu, Jun Li, et al.
Pageof 12